Improve cancer care through automated CT analysis
In-Med Oncoshield software automatically detects lesion in liver and pancreas in CT scans.
The tool automatically calculates volumes and identifies locations of lesion. This significantly enhances diagnostic capabilities and improve patient care especially in preparing for surgery. Our findings are highly accurate (>90% accuracy rate) and speedy.
Use Cases
Early Detection and Diagnosis
Oncoshield assists radiologists in the early detection of liver lesions. Early detection is crucial for prompt medical intervention and improved patient outcomes.
Monitoring Disease Progression
Oncoshield can be used to monitor the progression of liver diseases by regularly analyzing CT scans. This allows healthcare professionals to assess the effectiveness of treatments and make necessary adjustments.
Treatment Planning
In cases where surgical intervention or other treatments are requirement, Oncoshield can provide valuable information for treatment planning. It can help surgeons understand the location, size, and characteristics of lesions, aiding in decision making for the best course of action.
Improved Risk Stratification
By identifying lesions early, Oncoshield can help clinicians better stratify patients based on their risk, allowing for more personalized treatment plans.
Reducing workload for radiologists
Automation of lesion detection helps reduce radiologists workload and save their time. While the final diagnosis and treatment decisions should always involve a human healthcare professional,, Oncoshield can serve as vaulable tool for initial screening and identification of potential issues.
Clinical Trials and Research
Oncoshield can be used in medical research and clinical trials to analyze large datasets of CT liver scans. This can contribute to better understanding of liver diseases, treatment outcomes, and development of new therapies
Sounds Interesting?
We would love to you have you get firsthand experience of our best-in-class product.
Click below to claim your free trial.